Pharmaceutical News

RSS

New dopamine sensors could improve our understanding of Parkinson’s Disease

Researchers have developed a sensor that can measure dopamine in the brain for more than a year. The tech could help us understand Parkinson's and depression.

12 Sep 2018

PAREXEL launches Patient Innovation Center to improve drug development process

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center.

From Parexel 12 Sep 2018

Researchers design new medicine to treat highly aggressive pancreatic cancer

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

12 Sep 2018

Stimuli-responsive nanoparticles can specifically target infections to prevent spread of bacteria

Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes.

12 Sep 2018

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Novartis, a leader in immuno-dermatology, announced today new data from a patient preference survey showing psoriasis patients want their treatment to go beyond just clear skin and safety.

12 Sep 2018

Administering tPA depending on location of clot can be as effective as thrombectomy

There are two main treatments for stroke caused by a clot in a blood vessel in the brain. One treatment, mechanical thrombectomy, involves pulling the clot out with a specialized catheter that is inserted into the artery in the groin and guided by imaging to the clot.

12 Sep 2018

Nearly one in three opioid prescriptions in the US not justified, finds analysis

According to a nationwide analysis of physician visit records conducted by a team of researchers at Harvard Medical School and the RAND Corporation, nearly 30 percent of the outpatient opioid prescriptions made out in the United States do not have documented justification for their use.

12 Sep 2018

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health.

11 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units develop muscular weakness severe enough to impair their quality of life.

11 Sep 2018

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Platelet inhibition with aspirin is the cornerstone of medical therapy for coronary artery disease. In the era of percutaneous coronary intervention with drug-eluting stents, dual anti-platelet therapy with the addition of clopidogrel became the mainstay of therapy.

11 Sep 2018

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Anticoagulation is imperative to reduce the incidence of thrombotic complications in patients undergoing percutaneous interventional cardiovascular procedures; however, this is at the expense of increased risk of bleeding.

11 Sep 2018

Anticoagulant use in East Asian patients with nonvalvular atrial fibrillation

In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 215-226(12); DOI: https://doi.org/10.15212/CVIA.2017.0033 Chang-Sheng Ma from the Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China considers the use of direct oral anticoagulants for prevention of stroke and systemic embolic events in East Asian patients with nonvalvular atrial fibrillation.

11 Sep 2018

Medical cannabis provides relief across dozens of health symptoms, study shows

Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.

11 Sep 2018

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

7 Sep 2018

Researchers develop new generation of pain medications

Researchers from Charité - Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.

7 Sep 2018

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted approval to update the INVOKANA® and VOKANAMET® labeling to include changes to the indication statement for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

7 Sep 2018

Daytime sleepiness found to be a potential risk factor for Alzheimer’s disease

Older adults who frequently report feeling sleepy during the day are three times more likely to develop Alzheimer's in later life, according to a new study.

7 Sep 2018

Insulin’s high cost leads to deadly rationing

Diabetic ketoacidosis is a terrible way to die. It’s what happens when you don’t have enough insulin. Your blood sugar gets so high that your blood becomes highly acidic, your cells dehydrate, and your body stops functioning.

7 Sep 2018

Pharmaceutical News

New dopamine sensors could improve our understanding of Parkinson’s Disease

PAREXEL launches Patient Innovation Center to improve drug development process

Researchers design new medicine to treat highly aggressive pancreatic cancer

Stimuli-responsive nanoparticles can specifically target infections to prevent spread of bacteria

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Administering tPA depending on location of clot can be as effective as thrombectomy

Nearly one in three opioid prescriptions in the US not justified, finds analysis

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Anticoagulant use in East Asian patients with nonvalvular atrial fibrillation

Medical cannabis provides relief across dozens of health symptoms, study shows

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

Researchers develop new generation of pain medications

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

Daytime sleepiness found to be a potential risk factor for Alzheimer’s disease

Insulin’s high cost leads to deadly rationing

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News